LC–MS-MS Determination of Cytostatic Drugs on Surfaces and in Urine to Assess Occupational Exposure
Journal of Analytical Toxicology · 24.01.2023 · 46 (9) · e248-e255
DOI: 10.1093/jat/bkac073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Toxicology, online erschienen am 15.09.2022. Verfasst von José Ángel Lema-Atán und 5 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology Service, Institute of Forensic Sciences, University of Santiago de Compostela, Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Cytostatic Agents, Occupational Exposure. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The ever-increased usage of cytostatic drugs leads to high risk of exposure among healthcare workers. Moreover, workers are exposed to multiple compounds throughout their lives, leading to cumulative and chronic exposure. Therefore, multianalyte methods are the most suitable for exposure assessment, which minimizes the risks from handling cytostatic drugs and ensures adequate contamination containment. This study describes the development and full validation of two liquid chromatography–tandem mass spectrometry methods for the detection of gemcitabine, dacarbazine, methotrexate, irinotecan, cyclophosphamide, doxorubicinol, doxorubicin, epirubicin, etoposide, vinorelbine, docetaxel and paclitaxel in working surfaces and urine samples. The urine method is the first to measure vinorelbine and doxorubicinol. For surfaces, limits of detection (LOD) and limits of quantification (LOQ) were 5–100 pg/cm2, and linearity was achieved up to 500 pg/cm2. Inaccuracy was between −11.0 and 8.4%. Intra-day, inter-day and total imprecision were <20%, except for etoposide and irinotecan (<22.1%). In urine, LOD and LOQ were 5–250 pg/mL, with a linear range up to 1,000–5,000 pg/mL. Inaccuracy was between −3.8 and 14.9%. Imprecision was <12.4%. Matrix effect was from −58.3 to 1,268.9% and from −66.7 to 1,636% in surface and urine samples, respectively, and extraction efficiency from 10.8 to 75% and 47.1 to 130.4%, respectively. All the analytes showed autosampler (6°C/72 h), freezer (–22°C/2 months) and freeze/thaw (three cycles) stability. The feasibility of the methods was demonstrated by analyzing real working surfaces and patients’ urine samples. Contamination with gemcitabine, irinotecan, cyclophosphamide, epirubicin and paclitaxel (5–4,641.9 pg/cm2) was found on biological safety cabinets and outpatients’ bathrooms. Analysis of urine from patients under chemotherapy identified the infused drugs at concentrations higher than the upper LOQ. These validated methods will allow a comprehensive evaluation of both environmental and biological contamination in hospital settings and healthcare workers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Toxicology Service, Institute of Forensic Sciences, University of Santiago de Compostela, Santiago de Compostela, Spain.
ORCID-Profile: Elena Lendoiro, Ana de-Castro-Ríos
Zitieren
APA
Lema-Atán, J. Á., Lendoiro, E., Paniagua-González, L., Cruz, A., López-Rivadulla, M., & de-Castro-Ríos, A. (2023). LC–MS-MS Determination of Cytostatic Drugs on Surfaces and in Urine to Assess Occupational Exposure. Journal of Analytical Toxicology, 46(9), e248-e255. https://doi.org/10.1093/jat/bkac073
Vancouver
Lema-Atán JÁ, Lendoiro E, Paniagua-González L, Cruz A, López-Rivadulla M, de-Castro-Ríos A. LC–MS-MS Determination of Cytostatic Drugs on Surfaces and in Urine to Assess Occupational Exposure. Journal of Analytical Toxicology. 2023;46(9):e248-e255. doi:10.1093/jat/bkac073
BibTeX
@article{LemaAtn2023,
author = {Lema-Atán, José Ángel and Lendoiro, Elena and Paniagua-González, Lucía and Cruz, Angelines and López-Rivadulla, Manuel and de-Castro-Ríos, Ana},
title = {LC–MS-MS Determination of Cytostatic Drugs on Surfaces and in Urine to Assess Occupational Exposure},
journal = {Journal of Analytical Toxicology},
year = {2023},
volume = {46},
number = {9},
pages = {e248--e255},
doi = {10.1093/jat/bkac073}
}
EUVIMED